An invalid vocabulary is selected. Please change it in the options.
Titlesort descending Credits Start date - Expiration date
NCCN Guidelines® Updates: Breast Cancer - Treatment of HR-Positive, HER-Negative Early Stage Breast Cancer 0.36 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Discontinuing TKI Therapy in the Treatment of Chronic Myeloid Leukemia 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Management of Metastatic Colorectal Cancer 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Management of Metastatic Kidney Cancer 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Management of Muscle-Invasive Bladder Cancer 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Management of Prostate Cancer 0.79 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer 1.00 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Treatment of Pancreatic Cancer 0.56 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Harmonized Guidelines™ for Sub-Saharan Africa 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Task Force Report: Chimeric Antigen Receptor T-Cell Therapy 1.00 09/10/2018 - 12:00am to 09/10/2019 - 12:00am
Neoadjuvant and Adjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates 0.84 03/18/2019 - 12:00am to 03/18/2020 - 12:00am
New Biosimilar Approvals for Myeloid Growth Factors and Anemia 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
New Systemic Therapies for Metastatic Breast Cancer, Including SABCS Updates 0.85 03/18/2019 - 12:00am to 03/18/2020 - 12:00am
New Therapies for Ovarian Cancer 0.53 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
Novel Treatment Options for Neuroendocrine Tumors 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am

Pages